Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.

NCT ID: NCT05072327

Last Updated: 2021-10-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-15

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aim to investigate whether the prognosis of eyelid malignant tumor is better treated with Mohs surgery combind with cryotherapy than Mohs surgery only.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a randomized perspective study. American Joint Committee on Cancer was applied to define the cancer stage of patients recruited. Patients with Tis to T3cN0M0 will be randomized to receive Mohs surgery or Mohs suregery conbind cryotherapy. Patients will be followed for 3 years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eyelid Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mohs surgery conbind with cryotherapy

patients in this group received both Mohs surgery and cryotherapy.

Group Type EXPERIMENTAL

Mohs surgery

Intervention Type PROCEDURE

Mohs surgery of eyelid

cryotherapy

Intervention Type PROCEDURE

cryotherapy of eyelid

Mohs surgery

patients in this group received only Mohs surgery.

Group Type ACTIVE_COMPARATOR

Mohs surgery

Intervention Type PROCEDURE

Mohs surgery of eyelid

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mohs surgery

Mohs surgery of eyelid

Intervention Type PROCEDURE

cryotherapy

cryotherapy of eyelid

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ability to provide written informed consent and comply with study assessments for the full duration of this study.
* Definite pathology signs of eyelid basal cell carcinoma, squamous cell carcinoma and sebacous carcinoma, Stage Tis to T3CN0M0 based on American Joint Committee on Cancer.
* Pathological examination showed the primary tumor was compeletely resected

Exclusion Criteria

* Any previous treatment in the study eye
* Tumor complicated with infection
* Any other tumors of the paticipants
* Intolerate of surgery or anesthesia
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sun Yat-sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Huasheng Yang

Sun Yat-sen University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Huasheng Yang, Doctor

Role: STUDY_CHAIR

Zhongshan Ophthalmic Center, Sun Yat-sen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Huasheng Yang, M.D, PHD

Role: CONTACT

+862087331539

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Huasheng Yang, M.D, PHD

Role: primary

+862087331539

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

yanghs20200921

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.